Belite Bio, Inc (BLTE) stock
BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
$156.23−1.49 (-0.94%)
Close on Nov 18, 2026Market cap $6.15BP/E –Yield –
Belite Bio net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -$77.61M. The highest annual figure on record is -$5.75M in fiscal 2020.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$77.61M | – |
| FY2024 | Dec 31, 2024 | -$36.14M | – |
| FY2023 | Dec 31, 2023 | -$31.63M | – |
| FY2022 | Dec 31, 2022 | -$12.65M | – |
| FY2021 | Dec 31, 2021 | -$9.67M | – |
| FY2020 | Dec 31, 2020 | -$5.75M | – |
See a number that looks wrong?